“…Kurisu et al in 2005 reported high levels of circulating norepinephrine in a female patient as a result of inhaled salbutamol, but the patient also had a recent family death, a classic trigger of ABS (7) and until very recently the most significant risks reported with nebulized and oral beta-2-agonist use have been cardiovascular death, ischemic heart disease, and cardiac failure, but not ABS (8). Very recently, two other cases of ABS have been reported in status asthmaticus in which the development of apical ballooning was reported as a sequela of inhaled beta-2-agonists, but both cases were observed in females (6, 9). Most cases of ABS are observed in post-menopausal women (9) where sensitivity to raised catecholamine levels may be higher (1), leaving this case to be considered a rare presentation.…”